The FDA has recalled many of the specialized employees who were laid off recently, particularly those in the medical division, which lost around 180 jobs. Reports indicate that nearly all employees involved in reviewing medical devices and food safety are being brought back. The layoffs were originally part of cost-cutting measures initiated by the Trump administration. Interestingly, many of the roles reinstated were financed through fees paid by companies to the FDA, indicating the financial backdrop of these layoffs was not strictly taxpayer-funded, leading to ongoing layoffs in some sectors.
The FDA has reinstated dozens of specialized employees involved in crucial areas like food safety and medical device review, who were laid off last week.
Many of the reinstated positions were funded by industry fees rather than taxpayer dollars, revealing a potential misalignment in the downsizing strategy.
Collection
[
|
...
]